Gene · 8754
ADAM9: ADAM metallopeptidase domain 9
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. ADAM9: ADAM metallopeptidase domain 9. Genes, record 8754. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8754
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13443 | Disintegrin and metalloproteinase domain-containing protein 9 | 819 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents96
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4780859 A1 | 2026-07-29 | 2 | Q13443 | Espacenet |
| JP 2026515744 A | 2026-05-19 | 148 | Q13443 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36441 | Q13443 | Espacenet |
| EP 4653464 A2 | 2025-11-26 | 5 | Q13443 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 14331 | Q13443 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 16763 | Q13443 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 911 | Q13443 | Espacenet |
| EP 4641203 A2 | 2025-10-29 | 515 | Q13443 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 308 | Q13443 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 280 | Q13443 | Espacenet |
1 to 10 of 96
See all 96 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants969
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ADAM9 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 4 | 2025 |
| P30EY010572 | Ophthalmology Core Facility | 3 | 2025 |
| R01EY006855 | Models for Therapy of Hereditary Retinal Degeneration | 3 | 2025 |
| ZIABC006150 | DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs | 3 | 2025 |
| K24AR060297 | Scleroderma Twin Study and analysis of Estrogen in patients with dcSSc | 2 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 2 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 2 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 969Source NIH's project files
See all 969 nih grantsPapers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and functional experimental verification of efferocytosis-related diagnostic biomarkers for sepsis. | Int J Biochem Cell Biol | 2026 | 42777907 | PubTator, text mining | PubMed |
| Mechanisms related to increased susceptibility of the elderly lung to ventilator-induced lung injury: A scoping review. | Exp Gerontol | 2026 | 42735803 | PubTator, text mining | PubMed |
| Dissecting the Transcriptomic Profile of CD163+ Macrophages in Hepatocellular Carcinoma with VETC+ Angiogenesis Provides Potential Targets of Treatment. | Liver Cancer | 2026 | 42524682 | PubTator, text mining | PubMed |
| Collagen XVIIα1 in skin and hair aging: Mechanisms, stem cell niche regulation, and translational strategies. | J Dermatol Sci | 2026 | 42276855 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies ADAM9 as a key efferocytosis driver in lung adenocarcinoma. | Front Immunol | 2026 | 42266684 | PubTator, text mining | PubMed |
| Adam13 interacts with large protein complexes to regulate histone modification and gene expression. | Front Cell Dev Biol | 2026 | 42181688 | PubTator, text mining | PubMed |
| ADAM9: an updated view of its biology and pathology. | Mol Biol Rep | 2026 | 42171934 | PubTator, text mining | PubMed |
| A Theranostic Study of 177Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer. | Bioconjug Chem | 2026 | 42155035 | PubTator, text mining | PubMed |
| Evaluation of translational potential of mRNA vaccine candidate antigens for pancreatic cancer: a systematic review based on clinical evidence and stratified prioritization strategies. | Front Immunol | 2026 | 42131338 | PubTator, text mining | PubMed |
| M2 Macrophage membrane-mediated biomimetic nanoparticles carrying ADAM9 siRNA alleviate renal inflammation and fibrosis via the AKT/NF-κB pathway. | J Nanobiotechnology | 2026 | 42116024 | PubTator, text mining | PubMed |
1 to 10 of 1,799
See all 1,799 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8754
GET https://conductscience.org/api/genes/v1/8754/patents?page=2